C-RAD AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments: Positioning and Imaging. It offers Sentinel, a surface contour laser scanning system for patient positioning, monitoring, and gating applications; Gemini, a detector system for tumor localization; Orbiter, a radiation therapy system for radiotherapy treatment; and BioArtist, a system for biologically optimized radiation therapy. The company also offers Catalyst, a next generation optical surface scanning and re-projection hardware device coupled with optimized application software designed for work-flow integration, as well as distributes IBA Dosimetry products. It serves radiation treatment clinics and diagnostics departments in hospitals. C-RAD AB (publ) was founded in 2004 is headquartered in Uppsala, Sweden.
c-rad ab-b shs (CRADB:Stockholm)
Uppsala, 753 20
Phone: 46 18 66 69 30
Fax: 46 18 12 69 30www.c-rad.se
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for CRADB.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact C-RAD AB-B SHS, please visit www.c-rad.se. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.